Glia Nova Valuation Multiples

Glia Nova is valued at $2M as of November 2026. In the last fiscal year, Glia Nova EBITDA was ($57K).

Glia Nova Overview

About Glia Nova

Glia Nova Nyrt is engaged in the fields of biotechnology, agriculture and agri-informatics. The group develops novel and scalable algae technologies to bring widely accessible algae-based solutions to the market.


Founded

N/A

HQ

Hungary

Employees

N/A

Financials (Last FY)

Revenue: -
EBITDA: ($57K)

EV

$2M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Glia Nova Financials

Glia Nova reported last fiscal year revenue of - and negative EBITDA of ($57K).

In the same fiscal year, Glia Nova generated ($19K) in gross profit, ($57K) in EBITDA losses, and had net loss of ($61K).


Glia Nova P&L

In the most recent fiscal year, Glia Nova reported revenue of - and EBITDA of ($57K).

Glia Nova is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.

See analyst estimates for Glia Nova
Last FY2025202620272028
Gross Profit($19K)($19K)
EBITDA($57K)($57K)
Net Profit($61K)($61K)
Net Debt$130K-

Financial data powered by Morningstar, Inc.

Glia Nova Stock Performance

Glia Nova has current market cap of $2M, and enterprise value of $2M.

Market Cap Evolution


Glia Nova's stock price is $0.15.

Glia Nova share price decreased by 3.6% in the last 30 days, and by 41.8% in the last year.

Glia Nova has an EPS (earnings per share) of $-0.01.

See more trading valuation data for Glia Nova
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2M$2M-3.6%-3.6%-41.9%-41.8%$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Glia Nova Valuation Multiples

Glia Nova trades at (30.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Glia Nova

Glia Nova Financial Valuation Multiples

As of November 3, 2026, Glia Nova has market cap of $2M and EV of $2M.

Glia Nova has a P/E ratio of (25.5x).

Last FY2025202620272028
EV/EBITDA(30.7x)(30.7x)
EV/EBIT(35.8x)(35.8x)
EV/Gross Profit(92.7x)(92.7x)
P/E(25.5x)(25.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Glia Nova Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Glia Nova Competitors

Glia Nova competitors include Genomic Valley Biotech, Chromosome Dynamics, Edible Garden, Elixinol Wellness, Chucarapi, Above Food, AgroGalaxy, PRFoods, Africa Eats and Mary Agrotechnologies.

Most Glia Nova public comparables operate across Bioindustrials and Agriculture.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Genomic Valley Biotech$28K$5K54.8x-335.2x-
Chromosome Dynamics------
Edible Garden$13M($13M)1.7x1.4x(1.7x)-
Elixinol Wellness$11M($3M)0.4x-(1.2x)-
Chucarapi------
Above Food$264M($28M)0.0x-(0.1x)-
AgroGalaxy$850M($398M)0.2x-(0.4x)-
PRFoods$15M$57K0.7x-196.2x-

This data is available for Pro users. Sign up to see all Glia Nova competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Glia Nova

Where is Glia Nova headquartered?Glia Nova is headquartered in Hungary.
Is Glia Nova publicly listed?Yes, Glia Nova is a public company listed on Budapest Stock Exchange.
What is the stock symbol of Glia Nova?Glia Nova trades under GLIA ticker.
When did Glia Nova go public?Glia Nova went public in 2025.
Who are competitors of Glia Nova?Glia Nova main competitors include Genomic Valley Biotech, Chromosome Dynamics, Edible Garden, Elixinol Wellness, Chucarapi, Above Food, AgroGalaxy, PRFoods, Africa Eats, Mary Agrotechnologies.
What is the current market cap of Glia Nova?Glia Nova's current market cap is $2M.
Is Glia Nova profitable?No, Glia Nova is not profitable.
How many companies Glia Nova has acquired to date?Glia Nova hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Glia Nova has invested to date?Glia Nova hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Glia Nova

Lists including Glia Nova

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial